A Case of Vitiligo Induced by Diphenylcyclopropenone in a Patient with Malignant Melanoma.
- Author:
Chul Woo KIM
1
;
Young Jin KIM
;
Su Young KIM
;
Dong HOUH
;
Jong Ju LEE
Author Information
1. Department of Dermatology, College of Medicine, Hallym University Seoul, Korea. kim937121@hanmail.net
- Publication Type:Case Report
- Keywords:
DPCP(diphenylcyclopropenone);
Vitiligo;
Malignant melanoma
- MeSH:
Alopecia Areata;
Blister;
Humans;
Lymphatic Diseases;
Melanoma*;
Pruritus;
Toes;
Urticaria;
Vitiligo*;
Warts
- From:Korean Journal of Dermatology
2002;40(5):536-539
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
DPCP(diphencyclopropenone) has been used for the treatment of alopecia areata or verruca. Common side effects due to topical treatment with DPCP are pruritus, blistering, cervical lymphadenopathy and urticaria. Rarely, vitiligo can be induced by topical treatment with DPCP as a complication on the pigmentary system. Herein we report a case of vitiligo induced by DPCP in a patient with malignant melanoma. She was diagnosed with malignant melanoma in her 4th toe, Rt., a year ago. As part of adjuvant therapy, DPCP was topically applied to the inguinal area every week. After 4 months, vitiligo appeared on the area of DPCP application.
